6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm
- 12 July 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 58 (3), 258-264
- https://doi.org/10.1016/j.jacc.2011.02.052
Abstract
No abstract availableKeywords
Funding Information
- Biotronik
- Cordis
- Abbott Laboratories
- Medtronic
This publication has 12 references indexed in Scilit:
- Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisCirculation, 2010
- Coronary StentsJournal of the American College of Cardiology, 2010
- Percutaneous coronary intervention for small vessel coronary artery diseaseCardiovascular Revascularization Medicine, 2010
- Stent Expansion as a Mechanical Parameter to Predict Late Stent Patency: Back to the BasicsJACC: Cardiovascular Interventions, 2009
- Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque MorphologyJournal of the American College of Cardiology, 2008
- Comparison of in vivo acute stent recoil between the bioabsorbable everolimus‐eluting coronary stent and the everolimus‐eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trialsCatheterization and Cardiovascular Interventions, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trialsEuropean Heart Journal, 2005
- Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trialJournal of the American College of Cardiology, 2003
- Vessel Size and Long-Term Outcome After Coronary Stent PlacementCirculation, 1998